Business news

    US markets lower; Amazon hit by antitrust lawsuit; Moderna surged on teen vaccine success

    Article Image
    Highlights
    • The Nasdaq closed 0.03% lower on Tuesday at 13,657.
    • Amazon slipped on antitrust allegations over high prices for consumers.
    • Moderna stocks surged on Phase 3 teen trial of COVID-19 vaccine success.

    The US markets finished lower on Tuesday as economic data indicated consumer optimism has plateaued as the consumer confidence index dipped in May to 117.2.

    The Dow Jones fell 0.24% to finish the trading day down 82 points to close at 34,312 points.

    The tech heavy NASDAQ fell 0.03% to finish the trading day down 4 points to close at 13,657 points.

    One bitcoin is worth US$38,200 going into the Asian trading day.

    The Australian dollar is stronger against the major currencies and is buying 77.51 US cents.

    Amazon took a hit on Wall Street yesterday following news that the e-commerce giant is being sued by Washington D.C. Attorney General Karl Racine on antitrust grounds. The suit claims Amazon holds a monopoly power that prevents sellers from offering lower prices on other websites including their own which leads to higher prices for consumers.

    US biotech company Moderna surged on Tuesday after the company announced it?ll request global regulators to authorise its COVID-19 vaccine for teens following a successful Phase 3 study on 3732 individuals aged 12-17 resulting in an efficacy rate of 93% in teens with no previous exposure to the virus.

    And Airbnb is preparing for a summer of travel in the US by launching a host of new features including arrival guides, clearer cancellation policies, an ?I?m flexible? option and superhosts will gain access to more support agents who speak 42 different languages.

    Disclaimer

    Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relates to your unique circumstances. Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of, or reliance on the information provided directly or indirectly by use of this platform.

    Publisher
    Grafa